Grace Therapeutics, Inc. SEC filings GRCE

Grace Therapeutics, Inc. has 594 filings in SEC EDGAR's recent list, going back to Sep 2, 2008. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Grace Therapeutics, Inc. SEC filings
Form Description Filed Period
10-K Annual report Jun 18, 2026 Mar 31, 2026
10-K Annual report Jun 23, 2025 Mar 31, 2025
10-K Annual report Jun 21, 2024 Mar 31, 2024
10-K Annual report Jun 23, 2023 Mar 31, 2023
10-K/A Amended annual report Jul 29, 2022 Mar 31, 2022
10-K Annual report Jun 21, 2022 Mar 31, 2022
10-K Annual report Jun 22, 2021 Mar 31, 2021
10-K Annual report Jun 29, 2020 Mar 31, 2020
20-F Annual report (foreign issuer) Jun 26, 2019 Mar 31, 2019
20-F Annual report (foreign issuer) Jun 29, 2018 Mar 31, 2018
20-F Annual report (foreign issuer) Jun 27, 2017 Mar 31, 2017
20-F Annual report (foreign issuer) May 31, 2016 Feb 29, 2016
20-F Annual report (foreign issuer) Jun 16, 2015 Feb 28, 2015
20-F Annual report (foreign issuer) Jun 6, 2014 Feb 28, 2014
40-F Annual report (Canadian issuer) May 30, 2013 Feb 28, 2013

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRCE (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1444192
Former names
Acasti Pharma Inc. (until Oct 25, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.